Firms
Theme

IOSP

Innospec Inc. · NASDAQ

News

5 latest

Zacks Investment Research

Are Basic Materials Stocks Lagging Avient (AVNT) This Year?

Avient (AVNT) and Innospec (IOSP), both Basic Materials stocks with Zacks Rank #2 (Buy), are outperforming their sector peers year-to-date. AVNT has returned 24.8% versus the sector average of 9.5%, while IOSP has gained 26.2%. Both stocks have seen improving analyst sentiment with consensus EPS estimates increasing 4% over the past three months.

Mentions IOSP

Zacks Investment Research

Here's Why You Should Hold DOW Stock in Your Portfolio for Now

Dow Inc. (DOW) is benefiting from high-return growth projects, cost initiatives, and advantaged feedstock positions, with over $1.3 billion in self-help benefits expected in 2026. However, the company faces headwinds from soft demand, seasonal construction weakness, and elevated energy and feedstock costs. DOW carries a Zacks Rank #3 (Hold) rating.

Zacks Investment Research

RYAM Strengthens Jesup Operations With Altamaha Green Energy Project

Rayonier Advanced Materials (RYAM) announced a partnership with Albioma and the Beasley Group to construct the Altamaha Green Energy project, a 70-megawatt biomass cogeneration facility adjacent to its Jesup, Georgia manufacturing facility. RYAM will retain a 14% equity interest with an option to increase to 16%, and expects $8-10 million in annual distributions once operations begin in 2029. The project is projected to save RYAM $30 million in future capital expenditures while improving environmental performance and reliability.

Zacks Investment Research

Hawkins Expands Texas Water Treatment With Eagle Labs Buyout

Hawkins, Inc. (HWKN) has completed its acquisition of Eagle Labs, Inc., expanding its Water Treatment business into the Dallas-Fort Worth region of Texas. The acquisition adds two locations and brings HWKN's total Texas Water Treatment facilities to seven.

Zacks Investment Research

ASH's Shares Rally 30% in 6 Months: What's Driving the Upside?

Ashland Inc. (ASH) shares have surged 30.2% over the past six months, significantly outperforming its industry. The rally is driven by improved margin resilience from cost reductions and portfolio optimization, strong free cash flow generation of $103 million, and a doubled $1 billion share buyback authorization. The company's shift to a business-unit-focused operating model supports profitable growth in specialty chemicals.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $IOSP · 0 threads

Sign in to post on $IOSP

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev